News | April 26, 2013

Tomosynthesis may improve detection in dense breasts

April 26, 2013 — Two-dimensional plus 3-D breast imaging increases cancer detection rates by 11 percent, and could be particularly useful in detecting cancer in women with dense breasts, a new clinical study suggests.

Researchers at Yale University Smilow Cancer Hospital in New Haven, Conn., reviewed the screening mammograms of 14,684 patients. Forty-two cancers were found in 8,769 patients who had only 2-D imaging (a cancer detection rate of 4.8 per 1,000), said Jaime Geisel, a lead author of the study. Thirty-two cancers were found in the group that had 2-D plus 3-D (tomosynthesis) imaging, for a cancer detection rate of 5.4 per 1,000, said Geisel. The percent of invasive and intraductal cancers detected among the two groups was similar, she said.

In addition to the improved cancer detection rate, "of the patients who had cancer detected with 3-D, 54 percent had dense breasts. Of the patients who had cancer detected with 2-D only, 21 percent had dense breasts. This suggests better performance of the 3-D in dense breast tissue given 3-D was offered to patients regardless of breast density or risk factors," Geisel said.

Geisel noted that the majority of screening mammograms at her facility now include 3-D imaging.

"I am hopeful that my study will help raise awareness among physicians as well as women undergoing breast cancer screening," she said. Additional research needs to be done; "We recognize the numbers are still too small to draw significant conclusions, but the data is compelling," she said.

Geisel presented her study at the ARRS annual meeting on April 19 in Washington, D.C.


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
Subscribe Now